Cytoskeletal rescue of polarized atypical PKC in intestinal junctions under infla

描述（由申请人提供）：紧密连接的开放参与炎症性肠病（IBD）的发病机制。许多研究集中在Tyr激酶在去除紧密连接组分中的作用。然而，还没有人研究过非典型蛋白激酶C（aPKC），紧密连接的进化保守组织者，在炎症中的作用。我们的初步数据显示暴露于促炎信号的肠上皮细胞中aPKC急剧下降。我们还发现这种作用是转录后的，并且与aPKC的Hsp-70中间丝依赖性拯救机制有关。我们推测，翻译后机制，招募和维持非典型PKC在顶端域受损的炎症信号，导致在肠上皮细胞紧密连接通透性增加。我们的目标是：（1）确定Hsp 70分子伴侣拯救错误折叠的aPKC的分子机制。我们实验室开发的人肠细胞的组织培养、亚细胞分级分离和体外重建试验的组合将用于分析aPKC拯救机制的组分。(2)表征可拮抗aPKC活性构象丧失或降解的分子机制。Thr/Ser磷酸酶催化亚基的特异性敲低和正常缺乏它们的人细胞中角蛋白中间丝的表达将用于评估保护aPKC免于失去其活性构象或增强救援机制的可能机制。这些观察结果将在过度表达角蛋白中间丝的转基因小鼠中得到验证。(3)识别下调aPKC的促炎信号及其在维持aPKC生理水平的降解和拯救机制中的靶点。我们将筛选出除TNF-α外，还能降低aPKC水平的促炎细胞因子，并分析受促炎信号影响的aPKC激活和降解途径的步骤。同样，结果将在动物模型中得到验证 公共卫生相关性：IBD是一种慢性致残性疾病，影响约300万美国人。通过上皮肠屏障的渗透性增加不是原因，但它被广泛认为是使炎症持续的重要因素。本项目的研究旨在了解一种新的、尚未研究的组织和维持上皮屏障“紧密性”（紧密连接能力）的机制的分子基础。

DESCRIPTION (provided by applicant): Opening of tight junctions is involved in the pathogenesis of inflammatory bowel disease (IBD). Many studies have focused on the role of Tyr-kinases in the removal of tight junction components. However, no one has yet studied the role of atypical Protein Kinase C (aPKC), the evolutionarily conserved organizer of tight junctions, in inflammation. Our preliminary data shows a steep decrease of aPKC in intestinal epithelia exposed to pro- inflammatory signals. We have also shown that this effect is post-trancriptional and related to an Hsp-70- intermediate filament- dependent mechansim of rescue of aPKC. We hypothesize that post-translational mechanisms that recruit and maintain atypical PKC at the apical domain are impaired by inflammatory signals, resulting in increased tight junction permeability in the intestinal epithelium. We propose to: (1) Determine the molecular mechanisms by which Hsp70 chaperones rescue misfolded aPKC otherwise targeted for degradation. A combination of tissue culture of human intestinal cells, subcellular fractionation, and an in vitro reconstitution assay developed in our laboratory will be used to analyze the components of the aPKC rescue mechanisms. (2) Characterize molecular mechanisms that can antagonize loss of aPKC active conformation or degradation. Specific knock-down of Thr/Ser phosphatase catalytic subunits and expression of keratin intermediate filaments in human cells that normally lack them will be used to assess possible mechanisms to protect aPKC from losing its active conformation or to enhance the rescue mechanism. These observations will be validated in transgenic mice overexpressing keratin intermediate filaments. (3) Identify pro-inflammatory signals that downregulate aPKC and their targets in the degradation and rescue machinery that maintains aPKC physiologic levels. We will screen for pro-inflammatory cytokines that decrease aPKC levels, aside of TNF-, and analyze the step of the activation and degradation pathways of aPKC that are affected by pro-inflammatory signaling. Again, the results will be validated in an animal model PUBLIC HEALTH RELEVANCE: IBD is a chronic invalidating disease that affects around 3 million mericans. Increased permeability across the epithelial intestinal barrier is not the cause, but it is widely accepted as an important factor to perpetuate the inflammation. The studies in this project are intended to understand the molecular basis of a novel, as yet non studied mechanism to organize and maintain the "tightness" (tight junction competence) of the epithelial barrier.